Qualyst Inc Careers in Durham, NC

Qualyst was founded in 2001 on discoveries from breakthrough research in the School of Pharmacy at the University of North Carolina at Chapel Hill. Qualyst is the exclusive provider of B-CLEAR®, a patented sandwich-cultured hepatocyte platform and the only in vitro method to predict in vivo hepatic uptake, biliary excretion, and biliary clearance. B-CLEAR® is the only in vitro platform with certified uptake AND efflux transport. B-CLEAR® allows you to: Differentiate compounds for candidate selection by rank order according to potential for biliary excretion, intracellular concentration, and degree of hepatic accumulation Predict in vivo human biliary clearance potential prior to running clinical trials Evaluate interspecies differences in liver uptake, hepatic accumulation, intracellular concentration, and biliary excretion Identify drug-drug interactions related to hepatic uptake/efflux and assess possible clinical implications Improve hepatotoxicity predictions and yield in v